바이오인

Two trends in the research and development (R&D) of new medical products have been building throughout the last several decades, culminating in the expansion of academic-industry partnerships in numbers and types to such an extent that they have become a more prominent feature of the broader landscape of partnerships in biomedical innovation. On the academic side, the trend was commercialization of discoveries from basic research into medical products for the marketplace, a transformation facilitated by ground-breaking legislation in the U.S. beginning with the Bayh-Dole Act. On the industry side, it was externalization of the search for innovative R&D approaches and scientific knowledge in order to expand the capacity to address complex, unmet medical needs such as Alzheimer’s and Parkinson’s disease.